SEC Form 4 · accession 0001179110-18-011251
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James R Sulat
Director
Period of report
Sep 6, 2018
Accepted (ET)
Sep 10, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2018 | M | 13,500 | $14.79 | A | 39,734 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.79 | Sep 6, 2018 | M | 13,500 | D | Sep 12, 2011 | Sep 12, 2018 | Common Stock | 13,500 | 13,500 | D |